MAP2K7 and non-small cell lung carcinoma: We found that compared to wild-type miR-331-3p high-expressing cells, tumor cells with binding site mutations exhibited higher fluorescence levels (Figure 4A), indicating the specific binding of miR-331-3p to MAP2K7 protein in NSCLC cells.